-
公开(公告)号：WO2011022694A2
公开(公告)日：2011-02-24
申请号：PCT/US2010/046226
申请日：2010-08-20
Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE , MOORE, Bob, M. II , GURLEY, Steven , MUSTAFA, Suni
Inventor： MOORE, Bob, M. II , GURLEY, Steven , MUSTAFA, Suni
IPC: C07D491/048 , C07D409/04 , A61K31/519 , A61P35/00
CPC classification number: C07D491/048
Abstract: Furanopyrimidine cannabinoid analog compounds of the formula I are disclosed. The compounds are useful to modify the activity of CB 1 and CB2 receptors and treat conditions mediated by these receptors.
Abstract translation: 公开了式I的呋喃并嘧啶大麻素类似物。 该化合物可用于改变CB 1和CB 2受体的活性并治疗由这些受体介导的病症。
-
2.发明申请
公开(公告)号：WO2009143179A1
公开(公告)日：2009-11-26
申请号：PCT/US2009/044557
申请日：2009-05-19
Applicant: UNIVERSIYT OF TENNESSEE RESEARCH FOUNDATION, THE , MOORE, Bob, M. , GURLEY, Steven , MUSTAFA, Suni
Inventor： MOORE, Bob, M. , GURLEY, Steven , MUSTAFA, Suni
CPC classification number: C07D491/052
Abstract: Disclosed are compounds of the formula I: wherein R 1 , R 2 , V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
Abstract translation: 公开了式I的化合物：其中R 1，R 2，V，W，X，Y和Z可如本文所定义。 该化合物可用于治疗由大麻素受体介导的病症。
-
3.发明申请
公开(公告)号：WO2010045379A2
公开(公告)日：2010-04-22
申请号：PCT/US2009/060706
申请日：2009-10-14
Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE , GURLEY, Steven , MUSTAFA, Suni , MOORE, Bob, M
Inventor： GURLEY, Steven , MUSTAFA, Suni , MOORE, Bob, M
IPC: C07D239/52 , C07D213/69 , A61K31/505 , A61K31/44 , A61P35/00
CPC classification number: C07D409/06 , A61K31/44 , A61K31/505 , C07D213/69
Abstract: Disclosed are compounds of the formula (I): wherein R 1 , R 2 , V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
Abstract translation: 公开了式（I）的化合物：其中R 1，R 2，V，W，X，Y和Z可如本文所定义。 该化合物可用于治疗由大麻素受体介导的病症。
-
4.发明申请PYRIMIDINE NON-CLASSICAL CANNABINOID COMPOUNDS AND RELATED METHODS OF USE 审中-公开吡咯烷酮非经典的CANNABINOID化合物及其相关使用方法
公开(公告)号：WO2009143183A1
公开(公告)日：2009-11-26
申请号：PCT/US2009/044561
申请日：2009-05-19
Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE , MOORE, Bob, M., II , GURLEY, Steven , MUSTAFA, Suni , ALLISON, Patrick
Inventor： MOORE, Bob, M., II , GURLEY, Steven , MUSTAFA, Suni , ALLISON, Patrick
IPC: A01N43/54 , A61K31/505 , C07D239/42
CPC classification number: C07D239/52 , C07D409/06 , C07D409/14
Abstract: Disclosed are compounds of the following formula (I); wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
Abstract translation: 公开了下式（I）的化合物; 其中R1，R2，V，W，X，Y和Z可以如本文所定义。 该化合物可用于治疗由大麻素受体介导的病症。
-
5.发明申请PYRIMIDINE NON-CLASSICAL CANNABINOID COMPOUNDS AND RELATED METHODS OF USE 审中-公开吡咯烷酮非经典的CANNABINOID化合物及其相关使用方法
公开(公告)号：WO2010045377A2
公开(公告)日：2010-04-22
申请号：PCT/US2009/060702
申请日：2009-10-14
Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE , MOORE, Bob, M. , GURLEY, Steven , MUSTAFA, Suni , ALLISON, Patrick
Inventor： MOORE, Bob, M. , GURLEY, Steven , MUSTAFA, Suni , ALLISON, Patrick
IPC: C07D401/04 , C07D401/02 , C07D239/02 , C07D239/42 , A61K31/506 , A61P35/00
CPC classification number: C07D241/16 , C07D207/36 , C07D241/18 , C07D409/06
Abstract: Disclosed are compounds of the formula I: wherein R 1 , R 2 , V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
Abstract translation: 公开了式I的化合物：其中R 1，R 2，V，W，X，Y和Z可如本文所定义。 该化合物可用于治疗由大麻素受体介导的病症。
-
Patent Agency Ranking6.发明申请
公开(公告)号：WO2009143182A1
公开(公告)日：2009-11-26
申请号：PCT/US2009/044560
申请日：2009-05-19
Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE , MOORE, Bob, M., II , GURLEY, Steven , MUSTAFA, Suni , ALLISON, Patrick
Inventor： MOORE, Bob, M., II , GURLEY, Steven , MUSTAFA, Suni , ALLISON, Patrick
IPC: A01N43/16 , A61K31/35 , A61K31/505
CPC classification number: C07D491/052 , C07D491/04
Abstract: Disclosed are compounds of the following formula (I); wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
Abstract translation: 公开了下式（I）的化合物; 其中R1，R2，V，W，X，Y和Z可以如本文所定义。 该化合物可用于治疗由大麻素受体介导的病症。
-
公开(公告)号：WO2011022694A3
公开(公告)日：2011-06-16
申请号：PCT/US2010046226
申请日：2010-08-20
Applicant: UNIV TENNESSEE RES FOUNDATION , MOORE BOB M II , GURLEY STEVEN , MUSTAFA SUNI
Inventor： MOORE BOB M II , GURLEY STEVEN , MUSTAFA SUNI
IPC: C07D491/048 , A61K31/519 , A61P35/00 , C07D409/04
CPC classification number: C07D491/048
Abstract: Furanopyrimidine cannabinoid analog compounds of the formula I are disclosed. The compounds are useful to modify the activity of CB 1 and CB2 receptors and treat conditions mediated by these receptors.
Abstract translation: 公开了式I的呋喃并嘧啶大麻素类似物化合物。 这些化合物可用于修饰CB 1和CB 2受体的活性并治疗由这些受体介导的病症。
-
公开(公告)号：WO2011022692A2
公开(公告)日：2011-02-24
申请号：PCT/US2010/046222
申请日：2010-08-20
Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE , MOORE, Bob, M., II , GURLEY, Steven , MUSTAFA, Suni
Inventor： MOORE, Bob, M., II , GURLEY, Steven , MUSTAFA, Suni
IPC: C07D491/048 , C07D409/04 , C07D213/02 , A61K31/4355 , A61P35/00
CPC classification number: C07D491/04 , A61K31/4355
Abstract: Furanopyridine cannabinoid analog compounds of the formula (I) are disclosed. The compounds are useful to modify the activity of CB 1 and CB2 receptors and treat conditions mediated by these receptors.
Abstract translation: 公开了式（I）的呋喃并吡啶大麻素类似物化合物。 这些化合物可用于修饰CB 1和CB 2受体的活性并治疗由这些受体介导的病症。
-
9.发明申请PYRIMIDINE NON-CLASSICAL CANNABINOID COMPOUNDS AND RELATED METHODS OF USE 审中-公开吡咯烷酮非经典的CANNABINOID化合物及其相关使用方法
公开(公告)号：WO2010045377A3
公开(公告)日：2010-08-26
申请号：PCT/US2009060702
申请日：2009-10-14
Applicant: UNIV TENNESSEE RES FOUNDATION , MOORE BOB M , GURLEY STEVEN , MUSTAFA SUNI , ALLISON PATRICK
Inventor： MOORE BOB M , GURLEY STEVEN , MUSTAFA SUNI , ALLISON PATRICK
IPC: C07D401/04 , A61K31/506 , A61P35/00 , C07D239/02 , C07D239/42 , C07D401/02
CPC classification number: C07D241/16 , C07D207/36 , C07D241/18 , C07D409/06
Abstract: Disclosed are compounds of the formula (I): wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
Abstract translation: 公开了式（I）的化合物：其中R 1，R 2，V，W，X，Y和Z可如本文所定义。 该化合物可用于治疗由大麻素受体介导的病症。
-
公开(公告)号：WO2011022692A3
公开(公告)日：2011-06-16
申请号：PCT/US2010046222
申请日：2010-08-20
Applicant: UNIV TENNESSEE RES FOUNDATION , MOORE BOB M II , GURLEY STEVEN , MUSTAFA SUNI
Inventor： MOORE BOB M II , GURLEY STEVEN , MUSTAFA SUNI
IPC: C07D491/048 , A61K31/4355 , A61P35/00 , C07D213/02 , C07D409/04
CPC classification number: C07D491/04 , A61K31/4355
Abstract: Furanopyridine cannabinoid analog compounds of the formula (I) are disclosed. The compounds are useful to modify the activity of CB 1 and CB2 receptors and treat conditions mediated by these receptors.
Abstract translation: 公开了式（I）的呋喃并吡啶大麻素类似物。 该化合物可用于改变CB 1和CB 2受体的活性并治疗由这些受体介导的病症。
-
-
-
-
-
-
-
-
-
Search Results
14
records
(took 0.011 seconds)
